Exact Sciences Corp
Отворен
СекторЗдравеопазване
104.93
Преглед
Промяна на цената на акция
24 ч
Минимум
104.9
Максимум
104.96
Приходи | -66M -86M |
|---|---|
Продажби | 28M 878M |
EPS | -0.21 |
Марж на печалбата | -9.786 |
Служители | 7,100 |
EBITDA | -68M -20M |
Препоръки | Неутрален |
|---|---|
12-месечна прогноза | +0.09% upside |
Пазарна капитализация | 404M 20B |
|---|---|
Предишно отваряне | 104.93 |
Предишно затваряне | 104.93 |
Техническа оценка
By Trading Central
Увереност
Strong Bullish Evidence
Exact Sciences Corp Графика
Миналото представяне не гарантира бъдещи резултати.
Свързани новини
Сравнение с други в отрасъла
Ценова промяна
Exact Sciences Corp Прогноза
Ценова цел
By TipRanks
0.09% нагоре
12-месечна прогноза
Среден 105 USD 0.09%
Висок 105 USD
Нисък 105 USD
Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Exact Sciences Corp през последните три месеца.
Финанси
$
Относно Exact Sciences Corp
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
